Eric Topol

Jennifer Doudna and Priscilla Chan.

And so first, let me say, this is amazing to see this thing going forward.

It's an outgrowth of a New England Journal paper and monumental report on CRISPR in May.

So let me introduce first, maybe Dr. Doudna, Jennifer

is the Lee Ka Shing Chancellor's Chair and a professor in the Departments of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley.

She's also the subject of this book, one of my favorite books of all time, The Codebreaker.

And as you know, the 2020 Nobel Prize Laureate for her work in CRISPR-Cas9 genome editing.

And she founded the Innovative Genomics Institute back 10 years ago.

So Jennifer, welcome.

And now Dr. Priscilla Chan, who is the co-founder of the Chan Zuckerberg Initiative that also was started back in 2015.

So here we are a decade later, these two leaders.

She is a pediatrician having trained at UCSF and is committed to the initiative, which has as its mission statement to make it possible to cure, prevent, and manage all diseases in this century.

And so today we're going to talk about a step closer to that.

Welcome, Priscilla.

All right.

So I thought we'd start off by how did you two get together?

Have you known each other for over this past decade since you both got all your things going?

Well, that's pretty remarkable convergence leading up to today's announcement.

But I know, Priscilla, that you've been active in this rare disease space.

You've had at CZI a rare as one project.